Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DexCom, Inc. stock logo
DXCM
DexCom
$81.61
-2.1%
$84.17
$56.72
▼
$92.59
$30.35B1.455.03 million shs4.38 million shs
7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DexCom, Inc. stock logo
DXCM
DexCom
-2.06%+0.67%-5.15%-8.92%+40.56%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DexCom, Inc. stock logo
DXCM
DexCom
$81.61
-2.1%
$84.17
$56.72
▼
$92.59
$30.35B1.455.03 million shs4.38 million shs
7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DexCom, Inc. stock logo
DXCM
DexCom
-2.06%+0.67%-5.15%-8.92%+40.56%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
DexCom, Inc. stock logo
DXCM
DexCom
3.00
Buy$95.5017.02% Upside

Current Analyst Ratings Breakdown

Latest DXCM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/30/2026
DexCom, Inc. stock logo
DXCM
DexCom
Reiterated RatingStrong-Buy$94.00 ➝ $97.00
10/30/2026
DexCom, Inc. stock logo
DXCM
DexCom
Boost Price TargetBuy$90.00 ➝ $97.00
10/30/2026
DexCom, Inc. stock logo
DXCM
DexCom
Boost Price TargetBuy$102.00 ➝ $107.00
10/30/2026
DexCom, Inc. stock logo
DXCM
DexCom
Boost Price TargetNeutral$82.00 ➝ $85.00
10/30/2026
DexCom, Inc. stock logo
DXCM
DexCom
Boost Price TargetOverweight$115.00 ➝ $120.00
10/26/2026
DexCom, Inc. stock logo
DXCM
DexCom
Lower Price TargetOutperform$94.00 ➝ $87.00
10/13/2026
DexCom, Inc. stock logo
DXCM
DexCom
Set Price Target$95.00 ➝ $100.00
10/12/2026
DexCom, Inc. stock logo
DXCM
DexCom
Boost Price TargetBuy$90.00 ➝ $96.00
10/7/2026
DexCom, Inc. stock logo
DXCM
DexCom
Boost Price TargetOutperform$90.00 ➝ $110.00
10/7/2026
DexCom, Inc. stock logo
DXCM
DexCom
UpgradeStrong-Buy
(Data available from 11/17/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
DexCom, Inc. stock logo
DXCM
DexCom
$4.66B6.53$2.78 per share29.40$6.80 per share12.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
DexCom, Inc. stock logo
DXCM
DexCom
$836.30M$2.5532.0026.501.3419.42%37.77%15.98%N/A

Latest DXCM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/29/2026Q3 2026
DexCom, Inc. stock logo
DXCM
DexCom
$0.6750$0.73+$0.0550$0.72$1.33 billion$1.34 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
DexCom, Inc. stock logo
DXCM
DexCom
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
DexCom, Inc. stock logo
DXCM
DexCom
0.49
1.74
1.40

Institutional Ownership

CompanyInstitutional Ownership
DexCom, Inc. stock logo
DXCM
DexCom
97.75%

Insider Ownership

CompanyInsider Ownership
DexCom, Inc. stock logo
DXCM
DexCom
0.28%
CompanyEmployeesShares OutstandingFree FloatOptionable
DexCom, Inc. stock logo
DXCM
DexCom
11,000372.95 million371.91 millionOptionable

Recent News About These Companies

Is A Medicare Delay The Biggest Risk For DexCom Stock?
What Is Behind The Move In DexCom Stock?
Leerink Partners Reaffirms Their Buy Rating on Dexcom (DXCM)

New MarketBeat Followers Over Time

Media Sentiment Over Time

DexCom stock logo

DexCom NASDAQ:DXCM

$81.61 -1.72 (-2.06%)
Closing price 11/16/2026 04:00 PM Eastern
Extended Trading
$81.08 -0.53 (-0.64%)
As of 05:16 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.